Cytomos

Cytomos develops and commercializes AuraCyt, a scalable cell analysis platform enabling faster and cheaper biological drug discovery and development. Their benchtop cell analyzer, Celledonia, significantly enhances single-cell analysis, potentially transforming biopharma processes. The technology provides an unbiased approach to measuring cellular physiology based on intrinsic single-cell properties.

Buy Funded Startups lists

Funding Round:

Funding Amount: £5M

Date: 19-Nov-2024

Investors: Archangels, Old College Capital, Scottish Enterprise, British Business Bank

Markets: Biotech, Cell Analysis, Drug Discovery, Biologics Manufacturing, Biotechnology Research

HQ: Roslin, Scotland, United Kingdom

Founded: 2011

Website: https://www.cytomos.com/

LinkedIn: https://www.linkedin.com/company/cytomos

Twitter: https://twitter.com/cytomos

Instagram: